Cover Image
Market Research Report

Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2020-2024

Published by TechNavio (Infiniti Research Ltd.) Product code 773847
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2020-2024
Published: April 23, 2020 Content info: 120 Pages
Description

Global Respiratory Syncytial Virus Diagnostics Market 2020-2024

Technavio has been monitoring the respiratory syncytial virus diagnostics market and it is poised to grow by $ 585.17 million during 2020-2024 progressing at a CAGR of 10% during the forecast period. Our reports on respiratory syncytial virus diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in product launches, government and non-profit organization initiatives to diagnose RSV, and growing number of M&A. In addition, increase in product launches is anticipated to boost the growth of the market as well.

The respiratory syncytial virus diagnostics market analysis includes product segment and geographic landscapes

Technavio's ‘ respiratory syncytial virus diagnostics market ’ is segmented as below:

By Product:

  • Consumables
  • Systems

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the technological advancements as one of the prime reasons driving the respiratory syncytial virus diagnostics market growth during the next few years. Also, growing number of OEMs, and supportive initiatives by regulatory bodies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our respiratory syncytial virus diagnostics market covers the following areas:

  • Respiratory syncytial virus diagnostics market sizing
  • Respiratory syncytial virus diagnostics market forecast
  • Respiratory syncytial virus diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading respiratory syncytial virus diagnostics market vendors that include Abbott Laboratories, Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Quidel Corp., Seegene Inc., and Thermo Fisher Scientific Inc. Also, the respiratory syncytial virus diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR43463

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Force Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Consumables - Market size and forecast 2019-2024
  • Systems - Market size and forecast 2019-2024
  • Market opportunity by Product

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Quidel Corp.
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Product - Market share 2019-2024 (%)
  • 22: Comparison by Product
  • 23: Consumables - Market size and forecast 2019-2024 ($ million)
  • 24: Consumables - Year-over-year growth 2019-2024 (%)
  • 25: Systems - Market size and forecast 2019-2024 ($ million)
  • 26: Systems - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: Asia - Market size and forecast 2019-2024 ($ million)
  • 36: Asia - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Abbott Laboratories - Overview
  • 48: Abbott Laboratories - Business segments
  • 49: Abbott Laboratories - Key offerings
  • 50: Abbott Laboratories - Key customers
  • 51: Abbott Laboratories - Segment focus
  • 52: Becton, Dickinson and Co. - Overview
  • 53: Becton, Dickinson and Co. - Business segments
  • 54: Becton, Dickinson and Co. - Key offerings
  • 55: Becton, Dickinson and Co. - Key customers
  • 56: Becton, Dickinson and Co. - Segment focus
  • 57: bioMerieux SA - Overview
  • 58: bioMerieux SA - Business segments
  • 59: bioMerieux SA - Key offerings
  • 60: bioMerieux SA - Key customers
  • 61: bioMerieux SA - Segment focus
  • 62: Bio-Rad Laboratories Inc. - Overview
  • 63: Bio-Rad Laboratories Inc. - Business segments
  • 64: Bio-Rad Laboratories Inc. - Key offerings
  • 65: Bio-Rad Laboratories Inc. - Key customers
  • 66: Bio-Rad Laboratories Inc. - Segment focus
  • 67: Danaher Corp. - Overview
  • 68: Danaher Corp. - Business segments
  • 69: Danaher Corp. - Key offerings
  • 70: Danaher Corp. - Key customers
  • 71: Danaher Corp. - Segment focus
  • 72: F. Hoffmann-La Roche Ltd. - Overview
  • 73: F. Hoffmann-La Roche Ltd. - Business segments
  • 74: F. Hoffmann-La Roche Ltd. - Key offerings
  • 75: F. Hoffmann-La Roche Ltd. - Key customers
  • 76: F. Hoffmann-La Roche Ltd. - Segment focus
  • 77: Johnson & Johnson - Overview
  • 78: Johnson & Johnson - Business segments
  • 79: Johnson & Johnson - Key offerings
  • 80: Johnson & Johnson - Key customers
  • 81: Johnson & Johnson - Segment focus
  • 82: Quidel Corp. - Overview
  • 83: Quidel Corp. - Business segments
  • 84: Quidel Corp. - Key offerings
  • 85: Quidel Corp. - Key customers
  • 86: Quidel Corp. - Segment focus
  • 87: Seegene Inc. - Overview
  • 88: Seegene Inc. - Business segments
  • 89: Seegene Inc. - Key offerings
  • 90: Seegene Inc. - Key customers
  • 91: Seegene Inc. - Segment focus
  • 92: Thermo Fisher Scientific Inc. - Overview
  • 93: Thermo Fisher Scientific Inc. - Business segments
  • 94: Thermo Fisher Scientific Inc. - Key offerings
  • 95: Thermo Fisher Scientific Inc. - Key customers
  • 96: Thermo Fisher Scientific Inc. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations
Back to Top